Investee Partner oncgnostics

oncgnostics GmbH

oncg­nos­tics devel­ops highly reli­able mol­e­c­u­lar tests based on patented epi­ge­netic mark­ers for early detec­tion, treat­ment deci­sions and fol­low-up care in can­cer diagnostics.